CytomX Therapeutics Stock Rises This Week
Shares of clinical-stage biotech CytomX Therapeutics (NASDAQ: CTMX) surged by 43% this week following analyst Olivia Brayer from Cantor Fitzgerald ...
Tag: CytomX
News Summarized. Time Saved. Bite-sized news briefs for busy people. No fluff, just facts.